These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 23127784)

  • 1. Transplantation of GABAergic cells derived from bioreactor-expanded human neural precursor cells restores motor and cognitive behavioral deficits in a rodent model of Huntington's disease.
    McLeod MC; Kobayashi NR; Sen A; Baghbaderani BA; Sadi D; Ulalia R; Behie LA; Mendez I
    Cell Transplant; 2013; 22(12):2237-56. PubMed ID: 23127784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of GABAergic phenotype in a neural stem cell line for transplantation in an excitotoxic model of Huntington's disease.
    Bosch M; Pineda JR; Suñol C; Petriz J; Cattaneo E; Alberch J; Canals JM
    Exp Neurol; 2004 Nov; 190(1):42-58. PubMed ID: 15473979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spinal GABAergic transplants attenuate mechanical allodynia in a rat model of neuropathic pain.
    Mukhida K; Mendez I; McLeod M; Kobayashi N; Haughn C; Milne B; Baghbaderani B; Sen A; Behie LA; Hong M
    Stem Cells; 2007 Nov; 25(11):2874-85. PubMed ID: 17702982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transplantation of primed or unprimed mouse embryonic stem cell-derived neural precursor cells improves cognitive function in Alzheimerian rats.
    Moghadam FH; Alaie H; Karbalaie K; Tanhaei S; Nasr Esfahani MH; Baharvand H
    Differentiation; 2009; 78(2-3):59-68. PubMed ID: 19616885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transplanted adult neural progenitor cells survive, differentiate and reduce motor function impairment in a rodent model of Huntington's disease.
    Vazey EM; Chen K; Hughes SM; Connor B
    Exp Neurol; 2006 Jun; 199(2):384-96. PubMed ID: 16626705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multitarget basal ganglia dopaminergic and GABAergic transplantation strategy enhances behavioural recovery in parkinsonian rats.
    Mukhida K; Hong M; Miles GB; Phillips T; Baghbaderani BA; McLeod M; Kobayashi N; Sen A; Behie LA; Brownstone RM; Mendez I
    Brain; 2008 Aug; 131(Pt 8):2106-26. PubMed ID: 18669492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expansion of human neural precursor cells in large-scale bioreactors for the treatment of neurodegenerative disorders.
    Baghbaderani BA; Behie LA; Sen A; Mukhida K; Hong M; Mendez I
    Biotechnol Prog; 2008; 24(4):859-70. PubMed ID: 18380486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neural progenitor implantation restores metabolic deficits in the brain following striatal quinolinic acid lesion.
    Visnyei K; Tatsukawa KJ; Erickson RI; Simonian S; Oknaian N; Carmichael ST; Kornblum HI
    Exp Neurol; 2006 Feb; 197(2):465-74. PubMed ID: 16310773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurogenesis in the striatum of the quinolinic acid lesion model of Huntington's disease.
    Tattersfield AS; Croon RJ; Liu YW; Kells AP; Faull RL; Connor B
    Neuroscience; 2004; 127(2):319-32. PubMed ID: 15262322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implantation of the clinical-grade human neural stem cell line, CTX0E03, rescues the behavioral and pathological deficits in the quinolinic acid-lesioned rodent model of Huntington's disease.
    Yoon Y; Kim HS; Jeon I; Noh JE; Park HJ; Lee S; Park IH; Stevanato L; Hicks C; Corteling R; Barker RA; Sinden JD; Song J
    Stem Cells; 2020 Aug; 38(8):936-947. PubMed ID: 32374064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioural state differentially engages septohippocampal cholinergic and GABAergic neurons in R6/1 Huntington's disease mice.
    Ransome MI; Hannan AJ
    Neurobiol Learn Mem; 2012 Feb; 97(2):261-70. PubMed ID: 22261461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival, differentiation, and migration of bioreactor-expanded human neural precursor cells in a model of Parkinson disease in rats.
    Mukhida K; Baghbaderani BA; Hong M; Lewington M; Phillips T; McLeod M; Sen A; Behie LA; Mendez I
    Neurosurg Focus; 2008; 24(3-4):E8. PubMed ID: 18341411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alleviation of motor hyperactivity and neurochemical deficits by endocannabinoid uptake inhibition in a rat model of Huntington's disease.
    Lastres-Becker I; Hansen HH; Berrendero F; De Miguel R; Pérez-Rosado A; Manzanares J; Ramos JA; Fernández-Ruiz J
    Synapse; 2002 Apr; 44(1):23-35. PubMed ID: 11842443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Behavior characterization of a model of Huntington's disease in rats, induced by quinolinic acid].
    Francis L; Cruz R; Antúnez I; Rosillo JC
    Rev Neurol; 2000 Jun 1-15; 30(11):1016-21. PubMed ID: 10904945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuronal properties, in vivo effects, and pathology of a Huntington's disease patient-derived induced pluripotent stem cells.
    Jeon I; Lee N; Li JY; Park IH; Park KS; Moon J; Shim SH; Choi C; Chang DJ; Kwon J; Oh SH; Shin DA; Kim HS; Do JT; Lee DR; Kim M; Kang KS; Daley GQ; Brundin P; Song J
    Stem Cells; 2012 Sep; 30(9):2054-62. PubMed ID: 22628015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The IGF-I amino-terminal tripeptide glycine-proline-glutamate (GPE) is neuroprotective to striatum in the quinolinic acid lesion animal model of Huntington's disease.
    Alexi T; Hughes PE; van Roon-Mom WM; Faull RL; Williams CE; Clark RG; Gluckman PD
    Exp Neurol; 1999 Sep; 159(1):84-97. PubMed ID: 10486177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effect of encapsulated cells producing neurotrophic factor CNTF in a monkey model of Huntington's disease.
    Emerich DF; Winn SR; Hantraye PM; Peschanski M; Chen EY; Chu Y; McDermott P; Baetge EE; Kordower JH
    Nature; 1997 Mar; 386(6623):395-9. PubMed ID: 9121555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tenascin-R promotes neuronal differentiation of embryonic stem cells and recruitment of host-derived neural precursor cells after excitotoxic lesion of the mouse striatum.
    Hargus G; Cui Y; Schmid JS; Xu J; Glatzel M; Schachner M; Bernreuther C
    Stem Cells; 2008 Aug; 26(8):1973-84. PubMed ID: 18499893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal stem cells induced to secrete neurotrophic factors attenuate quinolinic acid toxicity: a potential therapy for Huntington's disease.
    Sadan O; Shemesh N; Barzilay R; Dadon-Nahum M; Blumenfeld-Katzir T; Assaf Y; Yeshurun M; Djaldetti R; Cohen Y; Melamed E; Offen D
    Exp Neurol; 2012 Apr; 234(2):417-27. PubMed ID: 22285250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proactive transplantation of human neural stem cells prevents degeneration of striatal neurons in a rat model of Huntington disease.
    Ryu JK; Kim J; Cho SJ; Hatori K; Nagai A; Choi HB; Lee MC; McLarnon JG; Kim SU
    Neurobiol Dis; 2004 Jun; 16(1):68-77. PubMed ID: 15207263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.